Cargando…
The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol
BACKGROUND: Macular oedema (MO) describes the accumulation of fluid in the central part of the retina, known as the ‘macula’ which provides central vision. MO is the leading cause of sight loss in patients with intraocular inflammation (uveitis). There is a lack of consensus over the treatment of uv...
Autores principales: | Tallouzi, Mohammad O., Moore, David J., Calvert, Melanie, Murray, Philip I., Bucknall, Nicholas, Denniston, Alastair K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752778/ https://www.ncbi.nlm.nih.gov/pubmed/26872918 http://dx.doi.org/10.1186/s13643-016-0203-y |
Ejemplares similares
-
COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis
por: Tallouzi, Mohammad O., et al.
Publicado: (2017) -
Healthcare professionals’ views on the most important outcomes for non-infectious uveitis of the posterior segment: A qualitative study
por: Tallouzi, Mohammad O., et al.
Publicado: (2023) -
Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative study
por: Tallouzi, Mohammad O, et al.
Publicado: (2020) -
Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018) -
Suprachoroidal triamcinolone acetonide versus rescue therapies for the treatment of uveitic macular oedema: A post hoc analysis of PEACHTREE
por: Singer, Michael A., et al.
Publicado: (2021)